Evogene (EVGN) — Capital Reinvestment Ratio
Latest as of December 2012:
2.78x
Evogene (EVGN) has a Capital Reinvestment Ratio of 2.78x as of December 2012, meaning it reinvests 3% of its operating cash flow (ILA100.00K) in capital expenditures (ILA278.00K). See EVGN equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
2.78x
Capex / Operating Cash Flow
Operating Cash Flow
ILA100.00K
ILA
Capital Expenditures
ILA278.00K
ILA
Data as of
Dec 2012
Most recent filing
Evogene Capital Reinvestment Ratio (2008–2011)
This chart tracks Evogene's Capital Reinvestment Ratio across 3 annual periods. Check EVGN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Evogene (2008–2011)
Year-by-year Capital Reinvestment Ratio for Evogene from 2008 to 2011. For live market cap and broader valuation context, see market value of Evogene.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 1.76x | ILA2.13 Million | ILA3.76 Million | ▼ -39.6% |
| 2009 | 2.92x | ILA886.00K | ILA2.59 Million | ▲ +3934.4% |
| 2008 | 0.07x | ILA12.61 Million | ILA912.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow